AI in healthcare faces growing state-level regulation

The rapid integration of artificial intelligence into healthcare is prompting a wave of regulatory efforts across US states. While federal agencies like the FDA have started to outline their roles in AI oversight, a growing number of states are not waiting. They are actively drafting legislation and guidance to address concerns ranging from algorithmic bias in diagnostics to the privacy of sensitive health data.

This decentralized approach to AI regulation means that what is permissible for an AI-powered diagnostic tool in one state might be restricted in another. Lobbyists and trade groups are now heavily engaged, trying to influence these nascent laws to ensure their technologies can operate broadly. This fragmentation creates a complex environment for developers and practitioners alike, demanding careful attention to local mandates.

Navigating the New Regulatory Landscape

One concrete example of this emerging landscape is California's proposed Assembly Bill 1281, which aims to establish an AI Council to advise on ethical deployment and consumer protection, specifically addressing health-related applications. Similarly, New York has considered measures for algorithmic transparency in healthcare decisions. These initiatives often focus on ensuring that AI systems do not perpetuate or exacerbate health disparities, particularly in underserved communities.

For you, as an individual using AI-powered health apps or services, these regulations will manifest in stricter data consent forms and more transparent explanations of how algorithms make recommendations. It means demanding clear answers from providers about how your health data is used, stored, and protected under the specific laws governing your location. Your ability to self-govern your health data will increasingly depend on understanding these evolving state-specific protections.